Pre-Tax Profit Margin (Annual)

Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues

Fortress Biotech, Inc. (FBIO) had Pre-Tax Profit Margin of -209.00% for the most recently reported fiscal year, ending 2024-12-31.

Quarterly Annual

Figures for fiscal year ending 2024-12-31

Income Statement Financials
Revenue	$57.67M
Net Income	$-55.89M
Cost of Goods Sold	$20.88M
Gross Profit	$36.80M
Operating Expenses	$168.05M
Operating Income	$-110.38M
Non-Operating Income/Expense	$-10.16M
Pre-Tax Income	$-120.54M
Normalized Pre-Tax Income	$-120.54M
Income after Taxes	$-120.86M
Income from Continuous Operations	$-120.86M
Consolidated Net Income/Loss	$-120.86M
Normalized Income after Taxes	$-120.86M
EBIT	$-110.38M
EBITDA	$-101.02M
Weighted-Average Shares Outstanding (Basic)	20.78M
Weighted-Average Shares Outstanding (Diluted)	20.78M
Earnings per Share (EPS) (Basic)	$-2.69
Earnings per Share (EPS) (Diluted)	$-2.69
Balance Sheet Financials
Current Assets	$90.37M
Property, Plant, and Equipment	$3.26M
Long-Term Assets	$53.85M
Total Assets	$144.22M
Current Liabilities	$71.40M
Long-Term Debt	$57.96M
Long-Term Liabilities	$74.47M
Total Liabilities	$145.87M
Common Equity	$-1.65M
Tangible Shareholders Equity	$-33.51M
Shareholders Equity	$-1.64M
Common Shares Outstanding	27.91M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-80.19M
Cash Flow from Investing Activities	$-15.00M
Cash Flow from Financial Activities	$70.64M
Beginning Cash	$83.36M
End Cash	$58.81M
Increase/Decrease in Cash	$-24.55M
Stock-Based Compensation	$32.73M
Common Stock Dividends Paid	$-0.69M
Preferred Stock Dividends Paid	$-4.02M
Fundamental Metrics & Ratios
Current Ratio	1.27
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	1.03
Debt to Equity Ratio	-35.64
Gross Margin	63.80%
Operating Margin	-191.38%
EBIT Margin	-191.38%
EBITDA Margin	-175.15%
Pre-Tax Profit Margin	-209.00%
Profit Margin	-96.91%
Free Cash Flow	$-80.19M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.40
Inventory Turnover	1.45
Receiveable Turnover	5.54
Days Sales in Receivables	65.83
Return on Equity	7337.92%
Return on Tangible Equity	360.69%
Return on Assets	-83.80%
Return on Investments	-214.59%
Book Value Per Share	$-0.06
Free Cash Flow per Share	$-3.86
Operating Cash Flow per Share	$-3.86

Data from Zacks Investment Research, Inc.